TScan Therapeutics Inc.

TScan Therapeutics Inc. annual/quarterly net income history and growth rate from 2020 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.

• TScan Therapeutics Inc. net income for the quarter ending March 31, 2026 was -28.7 M, a 16.00% decrease year-over-year.
• TScan Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -135.5 M, a 18.11% increase year-over-year.
• TScan Therapeutics Inc. annual net income for 2025 was -129.8 M, a 1.78% increase from 2024.
• TScan Therapeutics Inc. annual net income for 2024 was -127.5 M, a 42.91% increase from 2023.
• TScan Therapeutics Inc. annual net income for 2023 was -89.2 M, a 34.73% increase from 2022.
• TScan Therapeutics Inc. annual net income for 2022 was -66.2 M.